Finance

Lists
Why is AVTR down 3.26%?
Dive Deeper
AVTR:NYSE
Avantor Inc
US$15.14
-3.26%
(-0.51) 1D
US$15.14
0.00% (0.00)
After hours
Closed: ኖቬም 5, 4:00:04 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTR...
Open
US$15.60
High
US$15.67
Low
US$15.08
Mkt. cap
10.26 ቢ
Avg. vol.
9.92 ሚ
Volume
7.46 ሚ
P/E ratio
30.51
52-wk high
US$17.45
52-wk low
US$7.26
EPS
US$0.50
Beta
0.95
Shares outstanding
677.62 ሚ
No. of employees
14 ሺ
Open
US$15.60
High
US$15.67
Low
US$15.08
Mkt. cap
10.26 ቢ
Avg. vol.
9.92 ሚ
Volume
7.46 ሚ
P/E ratio
30.51
52-wk high
US$17.45
52-wk low
US$7.26
EPS
US$0.50
Beta
0.95
Shares outstanding
677.62 ሚ
No. of employees
14 ሺ
News stories
From web sources and news partners
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEO-
Employees13.5 ሺ
Founded1904
HeadquartersRadnor Township, ፔንስልቬኒያ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Analyst ratings
Based on 13 analysts giving stock ratings to AVTR in the past 3 months
Hold
Buy
1
Hold
11
Sell
1
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for AVTR in the last 3 months.
Highest
Current US$15.14
US$18.00 (+18.89%)
Average
US$16.63 (+9.84%)
Lowest
US$15.00 (-0.92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Casey Woodring
J.P. Morgan
Hold
Maintained
US$17.00
+12.3%
10/29/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
US$17.00
+12.3%
10/29/2026
Dan Leonard
RBC Capital
Hold
Reiterated
US$17.00
+12.3%
10/28/2026
Daniel Arias
Stifel Nicolaus
Hold
Maintained
US$18.00
+18.9%
10/29/2026
Luke Sergott
Barclays
Sell
Maintained
US$16.00
+5.7%
10/29/2026
Vijay Kumar
Evercore ISI
Hold
Maintained
US$17.00
+12.3%
10/28/2026
Robert Bamberger
Robert W. Baird
Buy
Maintained
US$17.00
+12.3%
10/27/2026
Eve Burstein
Bernstein
Hold
Reiterated
US$15.50
+2.4%
10/19/2026
Daniel Brennan
TD Cowen
Hold
Maintained
US$17.00
+12.3%
10/13/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Reiterated
US$15.00
-0.9%
10/13/2026
Lu Li
Bank of America Securities
Hold
Maintained
US$17.00
+12.3%
10/09/2026
Unknown Analyst
Bank of America Securities
Hold
Maintained
US$17.00
+12.3%
10/09/2026
Evan Stampler
Wells Fargo
Buy
Maintained
US$16.00
+5.7%
09/21/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
09/21/2026
Unknown Analyst
UBS
Hold
Initiated
US$16.00
+5.7%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
US$16.00
+5.7%
09/09/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
US$16.00
+5.7%
07/30/2026
Tycho Peterson
Jefferies
Hold
Upgraded
US$13.00
-14.1%
07/29/2026
Patrick B Donnelly
Citi
Hold
Maintained
US$11.00
-27.3%
07/08/2026
Michael Polark
Wolfe Research
Sell
Reiterated
US$7.00
-53.8%
06/01/2026
Unknown Analyst
RBC Capital
Hold
Initiated
US$9.00
-40.6%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
US$11.00
-27.3%
02/12/2026
Michael Ryskin
Bank of America Securities
Hold
Reiterated
US$11.00
-27.3%
02/11/2026
Last report
28 ኦክቶ 2026
Fiscal period
Q3 2026
US$0.22 / US$0.21
+5.61%beat
Revenue / Est. (USD)
1.70 ቢ / 1.64 ቢ
+3.49%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
1.66 ቢ
1.58 ቢ
1.69 ቢ
1.70 ቢ
Cost of goods sold
1.14 ቢ
1.08 ቢ
1.16 ቢ
1.16 ቢ
Cost of revenue
1.14 ቢ
1.08 ቢ
1.16 ቢ
1.16 ቢ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
354.70 ሚ
401.70 ሚ
415.80 ሚ
395.80 ሚ
Operating expense
354.70 ሚ
401.70 ሚ
415.80 ሚ
395.80 ሚ
Total operating expenses
1.49 ቢ
1.48 ቢ
1.57 ቢ
1.56 ቢ
Operating income
169.20 ሚ
99.00 ሚ
121.20 ሚ
139.00 ሚ
Other non operating income
-7.00 ሚ
-
100.00 ሺ
-
EBT including unusual items
80.80 ሚ
55.50 ሚ
81.20 ሚ
98.00 ሚ
EBT excluding unusual items
120.10 ሚ
56.10 ሚ
81.80 ሚ
98.80 ሚ
Income tax expense
28.40 ሚ
12.20 ሚ
43.10 ሚ
-105.40 ሚ
Effective tax rate
35.15%
21.98%
53.08%
-107.55%
Other operating expenses
-
-
-
-
Net income
52.40 ሚ
43.30 ሚ
38.10 ሚ
203.40 ሚ
Net profit margin
3.15%
2.74%
2.25%
11.98%
Earnings per share
0.22
0.17
0.21
0.22
Interest and investment income
11.40 ሚ
10.50 ሚ
10.30 ሚ
10.20 ሚ
Interest expense
-53.40 ሚ
-53.40 ሚ
-49.70 ሚ
-51.80 ሚ
Net interest expenses
-42.00 ሚ
-42.90 ሚ
-39.40 ሚ
-41.60 ሚ
Depreciation and amortization charges
-
-
-
-
EBITDA
272.50 ሚ
204.00 ሚ
226.80 ሚ
244.30 ሚ
Gain or loss from assets sale
5.10 ሚ
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google መተግበሪያዎች